Path ID: DB00545_MESH_D009157_1
Concepts
| Identifier | Name | Type |
|---|---|---|
| MESH:D011729 | pyridostigmine | Drug |
| UniProt:P22303 | Acetylcholinesterase | Protein |
| GO:0001507 | acetylcholine catabolic process in synaptic cleft | BiologicalProcess |
| HP:0011804 | Abnormal muscle physiology | PhenotypicFeature |
| MESH:D009157 | Myasthenia gravis | Disease |
Relationships
NOTE: predicates are annotated in Biolink Model (v1.3.0)
| Subject | Predicate | Object |
|---|---|---|
| Pyridostigmine | NEGATIVELY REGULATES | Acetylcholinesterase |
| Acetylcholinesterase | POSITIVELY REGULATES | Acetylcholine Catabolic Process In Synaptic Cleft |
| Acetylcholine Catabolic Process In Synaptic Cleft | AFFECTS RISK FOR | Abnormal Muscle Physiology |
| Abnormal Muscle Physiology | MANIFESTATION OF | Myasthenia Gravis |
Reference: